VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion

DOI: 10.1007/s12015-018-9821-1

Authors: Rachid Lahlil; Maurice Scrofani; Romain Barbet; Céline Tancredi; Anne Aries; Philippe Hénon

Step 1: mesoderm 1

day 0 ~ 2

culture “adherent” unknown species cell and human VSEL in “unspecified medium” for “2” days. For ECM, use “fibronectin/gelatin” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.

concentrationunit
valproic acid0.0025mol/l
5-azacytidine5.0e-7mol/l
Ascorbic Acid1.0e-8mol/l
TGF-beta1.0e-6g/l

Ideally, “mesoderm” should express “PDGFRa”, “KDR”, “MCAM”, “CD105”, “CD34”, “PTPRC” at the end of culture.